全球單克隆抗體在獸醫保健市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

全球獸醫保健市場對單克隆抗體的需求預計將從 2022 年的 718.09 萬美元達到 2030 年近 2741.58 萬美元的市場規模，2023-2030 年研究期間複合年複合成長率為 18.23%。

獸醫保健中的單克隆抗體（mAb）是指用於動物治療各種疾病和病症的一種靶向療法。這些是實驗室生產的分子，旨在模仿免疫系統響應感染或其他異物而產生的天然抗體。

市場動態：

動物中癌症和自身免疫性疾病等慢性疾病的患病率正在上升，這推動了單克隆抗體等靶向和特異性療法的採用。生物技術和基因工程的進步也提高了單克隆抗體的生產，提供更有效和專業的治療。獸醫的認知和接受度不斷提高，加上臨床試驗的積極結果，促進了它們的普及。不斷擴大的獸藥行業、對個性化和標靶治療的關注以及伴侶動物護理的改善進一步增加了對這些抗體的需求。此外，監管部門的批准以及研究機構和製藥公司之間的合作加速了單克隆抗體在獸醫健康領域的開發和可及性。隨著技術的成熟和成本變得更加易於管理，市場預計將持續成長，為動物提供新的和創新的治療選擇。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球獸醫健康單克隆抗體市場的各個細分市場進行了包容性評估。獸醫保健行業單克隆抗體的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲獸醫保健市場單克隆抗體當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。獸醫保健單克隆抗體市場的主要參與者包括 Zoetis、Merck & Co, Inc.、Elanco、Boehringer Ingelheim GmbH、Indian Immunologicals Ltd、Virbac。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

• 報告說明
  • 客觀的
  • 目標聽眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：單克隆抗體在獸醫健康領域的應用 - 行業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 行業動態
• 波特五力分析
• 市場吸引力分析
  • 按動物類型分類的市場吸引力分析
  • 市場吸引力分析：按應用分類
  • 最終用戶的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原料價格走勢
• 潛在買家名單
• 行銷管道
  • 直銷
  • 間接行銷
  • 行銷管道發展趨勢

第 5 章：全球獸醫保健單克隆抗體市場分析：按動物類型

• 按動物類型概述
• 歷史和預測數據
• 按動物類型分析
• 小狗
• 其他

第 6 章：獸醫保健市場中的全球單克隆抗體分析：按應用分類

• 概述：按應用
• 歷史和預測數據
• 分析：按應用
• 皮膚科
• 疼痛
• 其他

第 7 章：獸醫保健市場中的全球單克隆抗體分析：按最終用戶

• 最終用戶概述
• 歷史和預測數據
• 最終用戶分析
• 獸醫醫院
• 其他

第 8 章：獸醫保健市場中的全球單克隆抗體分析：按地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史和預測數據銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家/地區銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史和預測數據銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家/地區銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史和預測數據銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳大利亞銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史和預測數據銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家/地區銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史和預測數據銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 9 章：獸醫保健公司單克隆抗體的競爭格局

• 獸醫保健市場競爭中的單克隆抗體
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 10 章：公司簡介

• 公司股份分析
• 市場集中度
• Zoetis
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Merck & Co Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Elanco
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Boehringer Ingelheim GmbH
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Indian Immunologicals Ltd
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Virbac
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

The global demand for Monoclonal Antibodies in Veterinary Health Market is presumed to reach the market size of nearly USD 2741.58 MN by 2030 from USD 718.09 MN in 2022 with a CAGR of 18.23% under the study period 2023 - 2030.

Monoclonal antibodies (mAbs) in veterinary health refer to a type of targeted therapy used in animals to treat various diseases and conditions. These are laboratory-produced molecules designed to mimic the natural antibodies that the immune system produces in response to infections or other foreign substances.

MARKET DYNAMICS:

The prevalence of chronic diseases in animals, such as cancer and autoimmune disorders, is rising, which is driving the adoption of targeted and specific therapies like mAbs. Biotechnology and genetic engineering advancement have also improved the production of mAbs, offering more effective and specialized treatments. Growing awareness and acceptance among veterinarians, coupled with positive outcomes from clinical trials, have contributed to their popularity. The expanding veterinary pharmaceutical industry, focus on personalized and targeted therapies and improved companion animal care have further boosted the demand for these antibodies. Additionally, regulatory approvals and collaborations between research institutes and pharmaceutical companies have accelerated the development and accessibility of mAbs in veterinary health. As the technology matures and costs become more manageable, the market is expected to witness continued growth, offering new and innovative treatment options for animals.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of monoclonal antibodies in veterinary health. The growth and trends of monoclonal antibodies in veterinary health industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the monoclonal antibodies in veterinary health market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Animal Type

• Dogs
• Others

By Application

• Dermatology
• Pain
• Others

By End-User

• Veterinary Hospitals
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Monoclonal Antibodies in Veterinary Health market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Monoclonal Antibodies in Veterinary Health market include Zoetis, Merck & Co, Inc., Elanco, Boehringer Ingelheim GmbH, Indian Immunologicals Ltd, Virbac. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . MONOCLONAL ANTIBODIES IN VETERINARY HEALTH - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Animal Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET ANALYSIS BY ANIMAL TYPE

• 5.1 Overview by Animal Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Animal Type
• 5.4 Dogs Historic and Forecast Sales by Regions
• 5.5 Others Historic and Forecast Sales by Regions

6 . GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Dermatology Historic and Forecast Sales by Regions
• 6.5 Pain Historic and Forecast Sales by Regions
• 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-user
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-user
• 7.4 Veterinary Hospitals Historic and Forecast Sales by Regions
• 7.5 Others Historic and Forecast Sales by Regions

8 . GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE MONOCLONAL ANTIBODIES IN VETERINARY HEALTH COMPANIES

• 9.1. Monoclonal Antibodies In Veterinary Health Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF MONOCLONAL ANTIBODIES IN VETERINARY HEALTH INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Zoetis
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Merck & Co Inc.
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Elanco
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Boehringer Ingelheim GmbH
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Indian Immunologicals Ltd
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Virbac
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Animal Type (USD MN)
• Dogs Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Dermatology Market Sales by Geography (USD MN)
• Pain Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-user (USD MN)
• Veterinary Hospitals Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Monoclonal Antibodies In Veterinary Health Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Monoclonal Antibodies In Veterinary Health Report
• Market Research Process
• Market Research Methodology
• Global Monoclonal Antibodies In Veterinary Health Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Animal Type
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Animal Type (USD MN)
• Dogs Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Dermatology Market Sales by Geography (USD MN)
• Pain Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Veterinary Hospitals Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.